Filing Details
- Accession Number:
- 0000950170-25-005630
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-15 07:00:04
- Reporting Period:
- 2025-01-14
- Accepted Time:
- 2025-01-15 07:00:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1622229 | Cogent Biosciences Inc. | COGT | Pharmaceutical Preparations (2834) | 465308248 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2024135 | Cole Pinnow | C/O Cogent Biosciences, Inc. 275 Wyman Street, 3Rd Floor Waltham MA 02451 | Chief Commercial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-01-14 | 43,750 | $7.60 | 45,848 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $7.53 to $7.60. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.
- Includes an aggregate of 1,398 shares acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan on December 31, 2024.
Billionaire Hedge Funds
